Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 96

    1.

    Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes.

    Pereira MJ, Carvalho E, Eriksson JW, Crans DC, Aureliano M.

    J Inorg Biochem. 2009 Dec;103(12):1687-92. Epub 2009 Sep 26.PMID: 19850351 [PubMed - in process]Related articles

    2.

    Factors in serum from type 2 diabetes patients can cause cellular insulin resistance.

    Renström F, Burén J, Svensson MK, Eriksson JW.

    Horm Metab Res. 2009 Oct;41(10):767-72.PMID: 19764108 [PubMed - in process]Related articles

    3.

    Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: differences between men and women.

    Sjöholm K, Lundgren M, Olsson M, Eriksson JW.

    Cytokine. 2009 Dec;48(3):260-6. Epub 2009 Sep 15.PMID: 19758820 [PubMed - in process]Related articles

    4.

    Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.

    Ruge T, Lockton JA, Renstrom F, Lystig T, Sukonina V, Svensson MK, Eriksson JW.

    Metabolism. 2009 Jun;58(6):860-6.PMID: 19375766 [PubMed - indexed for MEDLINE]Related articles

    5.

    A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.

    Newcomer JW, Ratner RE, Eriksson JW, Emsley R, Meulien D, Miller F, Leonova-Edlund J, Leong RW, Brecher M.

    J Clin Psychiatry. 2009 Apr;70(4):487-99. Epub 2009 Apr 7.PMID: 19358783 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.

    Eriksson JW, Jansson PA, Carlberg B, Hägg A, Kurland L, Svensson MK, Ahlström H, Ström C, Lönn L, Ojbrandt K, Johansson L, Lind L.

    Hypertension. 2008 Dec;52(6):1030-7. Epub 2008 Nov 3.PMID: 18981327 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.

    Sahli D, Eriksson JW, Boman K, Svensson MK.

    Thromb Res. 2009 Mar;123(5):701-6. Epub 2008 Oct 21.PMID: 18945481 [PubMed - indexed for MEDLINE]Related articles

    8.

    Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients.

    Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JW, Gudbjörnsdottir S, Nyström L, Agardh CD, Landin-Olsson M, Sundkvist G, Groop LC.

    Diabetologia. 2008 Dec;51(12):2224-32. Epub 2008 Oct 7.PMID: 18839133 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sex- and depot-specific lipolysis regulation in human adipocytes: interplay between adrenergic stimulation and glucocorticoids.

    Lundgren M, Burén J, Lindgren P, Myrnäs T, Ruge T, Eriksson JW.

    Horm Metab Res. 2008 Dec;40(12):854-60. Epub 2008 Sep 25.PMID: 18819055 [PubMed - indexed for MEDLINE]Related articles

    10.

    Ketoacidosis occurs in both Type 1 and Type 2 diabetes--a population-based study from Northern Sweden.

    Wang ZH, Kihl-Selstam E, Eriksson JW.

    Diabet Med. 2008 Jul;25(7):867-70.PMID: 18644074 [PubMed - indexed for MEDLINE]Related articles

    11.

    Neuroendocrine mechanisms in insulin resistance.

    Sjöstrand M, Eriksson JW.

    Mol Cell Endocrinol. 2009 Jan 15;297(1-2):104-11. Epub 2008 May 27. Review.PMID: 18599191 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Reply on new drugs against type 2 diabetes: important to gain experience and knowledge]

    Sjöholm A, Agardh CD, Brismar K, Efendic S, Eliasson B, Eriksson JW, Frid A, Groop L, Holmgren J, Ridderstråle M, Smith U.

    Lakartidningen. 2008 Apr 23-May 6;105(17-18):1310, 1312. Swedish. No abstract available. PMID: 18561535 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Toe blood pressure measurement better than ankle blood pressure measurement in patients with diabetes]

    Svensson MK, Eriksson JW.

    Lakartidningen. 2008 Mar 18-Apr 1;105(12-13):925-6. Swedish. No abstract available. PMID: 18461865 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk.

    Möllsten A, Kockum I, Svensson M, Rudberg S, Ugarph-Morawski A, Brismar K, Eriksson JW, Dahlquist G.

    J Diabetes Complications. 2008 Nov-Dec;22(6):377-83. Epub 2008 Apr 16.PMID: 18413189 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin action and signalling in fat and muscle from dexamethasone-treated rats.

    Burén J, Lai YC, Lundgren M, Eriksson JW, Jensen J.

    Arch Biochem Biophys. 2008 Jun 1;474(1):91-101. Epub 2008 Feb 29.PMID: 18328801 [PubMed - indexed for MEDLINE]Related articles

    16.

    Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002.

    Ostman J, Lönnberg G, Arnqvist HJ, Blohmé G, Bolinder J, Ekbom Schnell A, Eriksson JW, Gudbjörnsdottir S, Sundkvist G, Nyström L.

    J Intern Med. 2008 Apr;263(4):386-94. Epub 2008 Jan 16.PMID: 18205768 [PubMed - indexed for MEDLINE]Related articles

    17.

    Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus.

    Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B.

    Nutr Metab Cardiovasc Dis. 2008 Sep;18(7):503-10. Epub 2007 Nov 26.PMID: 18042359 [PubMed - indexed for MEDLINE]Related articles

    18.

    Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia.

    Norberg M, Stenlund H, Lindahl B, Andersson C, Weinehall L, Hallmans G, Eriksson JW.

    Obesity (Silver Spring). 2007 Jul;15(7):1875-85.PMID: 17636107 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance.

    Eriksson JW.

    FEBS Lett. 2007 Jul 31;581(19):3734-42. Epub 2007 Jun 27. Review.PMID: 17628546 [PubMed - indexed for MEDLINE]Related articles

    20.

    Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden.

    Torffvit O, Eriksson JW, Henricsson M, Sundkvist G, Arnqvist HJ, Blohmé G, Bolinder J, Nyström L, Ostman J, Svensson M.

    J Diabetes Complications. 2007 Jul-Aug;21(4):246-51.PMID: 17616355 [PubMed - indexed for MEDLINE]Related articles

    21.

    Short-term effects of metformin in type 2 diabetes.

    Eriksson A, Attvall S, Bonnier M, Eriksson JW, Rosander B, Karlsson FA.

    Diabetes Obes Metab. 2007 Jul;9(4):483-9.PMID: 17587390 [PubMed - indexed for MEDLINE]Related articles

    22.

    Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes.

    Abraham NG, Brunner EJ, Eriksson JW, Robertson RP.

    Ann N Y Acad Sci. 2007 Oct;1113:256-75. Epub 2007 May 18. Review.PMID: 17513461 [PubMed - indexed for MEDLINE]Related articles

    23.

    Short-term effects of metformin in type 2 diabetes.

    Eriksson A, Attvall S, Bonnier M, Eriksson JW, Rosander B, Karlsson FA.

    Diabetes Obes Metab. 2007 May;9(3):330-6.PMID: 17391159 [PubMed - indexed for MEDLINE]Related articles

    24.

    Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.

    Kalani M, Silveira A, Blombäck M, Apelqvist J, Eliasson B, Eriksson JW, Fagrell B, Torffvit O, Hamsten A, Jörneskog G.

    Thromb Res. 2007;120(5):653-61. Epub 2007 Feb 2.PMID: 17275886 [PubMed - indexed for MEDLINE]Related articles

    25.

    Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes.

    Renström F, Burén J, Svensson M, Eriksson JW.

    Metabolism. 2007 Feb;56(2):190-8.PMID: 17224332 [PubMed - indexed for MEDLINE]Related articles

    26.

    Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

    Lundgren M, Svensson M, Lindmark S, Renström F, Ruge T, Eriksson JW.

    Diabetologia. 2007 Mar;50(3):625-33. Epub 2007 Jan 10.PMID: 17216279 [PubMed - indexed for MEDLINE]Related articles

    27.

    Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS).

    Littorin B, Blom P, Schölin A, Arnqvist HJ, Blohmé G, Bolinder J, Ekbom-Schnell A, Eriksson JW, Gudbjörnsdottir S, Nyström L, Ostman J, Sundkvist G.

    Diabetologia. 2006 Dec;49(12):2847-52. Epub 2006 Oct 27.PMID: 17072585 [PubMed - indexed for MEDLINE]Related articles

    28.

    Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women.

    Norberg M, Stenlund H, Lindahl B, Andersson C, Eriksson JW, Weinehall L.

    Diabetes Res Clin Pract. 2007 Jun;76(3):368-77. Epub 2006 Oct 10.PMID: 17034894 [PubMed - indexed for MEDLINE]Related articles

    29.

    Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo.

    Lindmark S, Burén J, Eriksson JW.

    Clin Endocrinol (Oxf). 2006 Sep;65(3):301-9.PMID: 16918948 [PubMed - indexed for MEDLINE]Related articles

    30.

    A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

    Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

    J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491. PMID: 16918824 [PubMed - indexed for MEDLINE]Related articles

    31.

    HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden.

    Bakhtadze E, Borg H, Stenström G, Fernlund P, Arnqvist HJ, Ekbom-Schnell A, Bolinder J, Eriksson JW, Gudbjörnsdottir S, Nyström L, Groop LC, Sundkvist G.

    Diabetologia. 2006 Aug;49(8):1785-94. Epub 2006 May 31.PMID: 16783473 [PubMed - indexed for MEDLINE]Related articles

    32.

    Insulin resistance in diabetic nephropathy--cause or consequence?

    Svensson M, Eriksson JW.

    Diabetes Metab Res Rev. 2006 Sep-Oct;22(5):401-10. Review.PMID: 16703644 [PubMed - indexed for MEDLINE]Related articles

    33.

    Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden.

    Waernbaum I, Blohmé G, Ostman J, Sundkvist G, Eriksson JW, Arnqvist HJ, Bolinder J, Nyström L.

    Diabetologia. 2006 Apr;49(4):653-9. Epub 2006 Jan 31. Erratum in: Diabetologia. 2006 Jun;49(6):1457. PMID: 16447054 [PubMed - indexed for MEDLINE]Related articles

    34.

    Lipoprotein lipase activity/mass ratio is higher in omental than in subcutaneous adipose tissue.

    Ruge T, Sukonina V, Myrnäs T, Lundgren M, Eriksson JW, Olivecrona G.

    Eur J Clin Invest. 2006 Jan;36(1):16-21.PMID: 16403005 [PubMed - indexed for MEDLINE]Related articles

    35.

    Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetes.

    Bolinder J, Fernlund P, Borg H, Arnqvist HJ, Björk E, Blohmé G, Eriksson JW, Nyström L, Ostman J, Sundkvist G.

    Scand J Clin Lab Invest. 2005;65(7):585-94.PMID: 16271990 [PubMed - indexed for MEDLINE]Related articles

    36.

    Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?

    Burén J, Eriksson JW.

    Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):487-94. Review.PMID: 15977304 [PubMed - indexed for MEDLINE]Related articles

    37.

    Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance.

    Lindmark S, Lönn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW.

    Obes Res. 2005 Apr;13(4):717-28.PMID: 15897481 [PubMed - indexed for MEDLINE]Related articles

    38.

    Evaluation of simple non-invasive techniques for assessment of lower extremity arterial disease.

    Sahli D, Svensson M, Lidgren J, Ojbrandt K, Eriksson JW.

    Clin Physiol Funct Imaging. 2005 May;25(3):129-34. Erratum in: Clin Physiol Funct Imaging. 2005 Sep;25(5):311. PMID: 15888091 [PubMed - indexed for MEDLINE]Related articles

    39.

    Insulin receptor substrates-1 and -2 are both depleted but via different mechanisms after down-regulation of glucose transport in rat adipocytes.

    Renström F, Burén J, Eriksson JW.

    Endocrinology. 2005 Jul;146(7):3044-51. Epub 2005 Apr 21.PMID: 15845625 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Short-term effects of repetitive arm work and dynamic exercise on glucose metabolism and insulin sensitivity.

    Bergfors M, Barnekow-Bergkvist M, Kalezic N, Lyskov E, Eriksson JW.

    Acta Physiol Scand. 2005 Apr;183(4):345-56.PMID: 15799771 [PubMed - indexed for MEDLINE]Related articles

    41.

    The risk of venous thromboembolism is markedly elevated in patients with diabetes.

    Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW.

    Diabetologia. 2005 May;48(5):1017-21. Epub 2005 Mar 19.PMID: 15778859 [PubMed - indexed for MEDLINE]Related articles

    42.

    Tissue-specific regulation of lipoprotein lipase in humans: effects of fasting.

    Ruge T, Svensson M, Eriksson JW, Olivecrona G.

    Eur J Clin Invest. 2005 Mar;35(3):194-200.PMID: 15733074 [PubMed - indexed for MEDLINE]Related articles

    43.

    Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies.

    Giorgino F, Laviola L, Eriksson JW.

    Acta Physiol Scand. 2005 Jan;183(1):13-30. Review.PMID: 15654917 [PubMed - indexed for MEDLINE]Related articles

    44.

    Assessment of toe blood pressure is an effective screening method to identify diabetes patients with lower extremity arterial disease.

    Sahli D, Eliasson B, Svensson M, Blohmé G, Eliasson M, Samuelsson P, Ojbrandt K, Eriksson JW.

    Angiology. 2004 Nov-Dec;55(6):641-51.PMID: 15547650 [PubMed - indexed for MEDLINE]Related articles

    45.

    [Exciting findings can change the view on the pathogenesis of type 2 diabetes. Impaired mitochondrial function can explain metabolic disorders in several organs]

    Eriksson JW.

    Lakartidningen. 2004 Sep 23;101(39):2992-3. Swedish. No abstract available. PMID: 15493637 [PubMed - indexed for MEDLINE]Related articles

    46.

    Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.

    Tan MH, Johns D, Strand J, Halse J, Madsbad S, Eriksson JW, Clausen J, Konkoy CS, Herz M; GLAC Study Group.

    Diabet Med. 2004 Aug;21(8):859-66.PMID: 15270789 [PubMed - indexed for MEDLINE]Related articles

    47.

    Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes.

    Lundgren M, Burén J, Ruge T, Myrnäs T, Eriksson JW.

    J Clin Endocrinol Metab. 2004 Jun;89(6):2989-97.PMID: 15181089 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    No in vitro effects of fatty acids on glucose uptake, lipolysis or insulin signaling in rat adipocytes.

    Lundgren M, Eriksson JW.

    Horm Metab Res. 2004 Apr;36(4):203-9.PMID: 15114517 [PubMed - indexed for MEDLINE]Related articles

    49.

    Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes.

    Schölin A, Törn C, Nyström L, Berne C, Arnqvist H, Blohmé G, Bolinder J, Eriksson JW, Kockum I, Landin-Olsson M, Ostman J, Karlsson FA, Sundkvist G, Björk E.

    Diabet Med. 2004 May;21(5):447-55.PMID: 15089789 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...